By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novalar Pharmaceuticals, Inc. 

12555 High Bluff Drive
Suite 300
San Diego  California  92130  U.S.A.
Phone: 858-436-1100 Fax: 858-436-1101


SEARCH JOBS


Industry
Pharmaceutical






Company News
Novalar Pharmaceuticals, Inc. Plans Shutdown Following Sale of OraVerse to Septodont, to Cut 12 Jobs 3/23/2011 7:05:49 AM
Novalar Pharmaceuticals, Inc. Announces Acquisition of OraVerse(R) by Septodont 3/21/2011 8:38:29 AM
Novalar Pharmaceuticals, Inc. Makes OraVerse(R) Product Donation to National Children's Oral Health Foundation 12/1/2010 7:09:10 AM
Sanofi-Aventis (France) (SASY.PA) And Novalar Pharmaceuticals, Inc. File Marketing Authorization Application for OraVerse(R) in Five Key European Countries 7/14/2010 11:47:52 AM
Novalar Pharmaceuticals, Inc. Reaches Agreement With H.A. Systems to Distribute OraVerse(R) in Israel 5/17/2010 9:54:45 AM
Novalar Pharmaceuticals, Inc. Presents Results of OraVerse(R) Dental Practice Survey at American Association of Dental Research Meeting 3/5/2010 9:55:46 AM
Sanofi-Aventis (France) (SASY.PA) and Novalar Pharmaceuticals, Inc. Enter Exclusive License Agreement to Commercialize OraVerse(R) in Germany 3/3/2010 9:00:46 AM
Novalar Pharmaceuticals, Inc. Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent; Hires Additional 27 2/27/2009 12:03:38 PM
Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse(TM) 5/12/2008 6:31:57 AM
Novalar Pharmaceuticals, Inc. Strengthens Senior Management Team With Key Appointments 12/18/2007 8:43:39 AM
12
//-->